Your browser doesn't support javascript.
loading
Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study.
Shi, Tingyan; Xiang, Libing; Zhu, Jianqing; Liu, Jihong; Zhang, Ping; Wang, Huaying; Feng, Yanling; Zhu, Tao; Zhang, Yingli; Yu, Aijun; Jiang, Wei; Wang, Xipeng; Zhu, Yaping; Wu, Sufang; Teng, Yincheng; Zhang, Jiejie; Jiang, Rong; Zhang, Wei; Jia, Huixun; Zang, Rongyu.
Afiliação
  • Shi T; Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Xiang L; Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhu J; Department of Gynecologic Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Liu J; Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhang P; Department of Gynecologic Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Wang H; Department of Gynecologic Oncology, Fudan University Cancer Hospital, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Feng Y; Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhu T; Department of Gynecologic Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Zhang Y; Department of Gynecologic Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Yu A; Department of Gynecologic Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Jiang W; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Wang X; Department of Obstetrics and Gynecology, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhu Y; Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai, China.
  • Wu S; Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai, China.
  • Teng Y; Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang J; Department of Gynecologic Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Jiang R; Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhang W; Department of Biostatistics, Fudan University, Shanghai, China.
  • Jia H; Clinical Statistics Center, Shanghai General Hospital, Shanghai, China.
  • Zang R; Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
J Gynecol Oncol ; 33(4): e63, 2022 07.
Article em En | MEDLINE | ID: mdl-35775688
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Procedimentos Cirúrgicos de Citorredução Tipo de estudo: Diagnostic_studies Limite: Female / Humans Idioma: En Revista: J Gynecol Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Coréia do Sul
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Procedimentos Cirúrgicos de Citorredução Tipo de estudo: Diagnostic_studies Limite: Female / Humans Idioma: En Revista: J Gynecol Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Coréia do Sul